•  
  •  
  •  
  •  

2025-08-08 22:03:57

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group

Keywords Selected:  IDFC

Stock Report

  • DFC Commits US$20 Million Long-Term Loan to Panacea Biotec Towards Capacity-Expansion Project for Hexavalent Vaccine
  • IDFC receives IT refund of Rs. 202.55 crores
  • IDFC Ltd recommends interim dividend of Rs. 1
  • NOD for IDFC First Bank Amalgamation
  • IDFC Ltd reports consolidated PAT of Rs. 347.85 crores in Q4 FY2024
  • IDFC reports consolidated net profit of Rs. 210.04 crores in Q3 FY24
  • IDFC posts fall in consolidated Q2 FY24 PAT to Rs. 223.54 crores
  • IDFC Ltd posts consolidated PAT of Rs. 264.15 crores in Q1FY24
  • Board of Directors of IDFC FIRST Bank approves amalgamation of IDFC Limited with IDFC FIRST Bank
  • IDFC posts consolidated PAT of Rs. 3387.39 crores in Q4 FY2023
  • IDFC Ltd completes corporate restructuring, declares special dividend
  • IDFC Ltd declares special interim dividend of Rs. 11
  • IDFC Ltd Q3 FY23 consolidated net profit at Rs. 272.05 crores
  • IDFC Limited appoints Mr. Mahendra N Shah as MD
  • IDFC Ltd consolidated Q4FY22 profit at Rs. 194.16 crores
  • Bandhan Financial Holdings, GIC and ChrysCapital consortium set to acquire IDFC AMC
  • IOB to fund Rs. 1000 Crore for Infrastructure Development in Union Territory of Jammu and Kashmir
  • IDFC consolidated Q3 FY2022 profit at Rs. 18.23 crores
  • IDFC FIRST Bank Limited board approves in-principle merger of IDFC Limited
  • Mr. Anil Singhvi appointed as Chairman of IDFC Ltd
  • IDFC Ltd Consolidated PAT at Rs. 261.89 crores in Q2FY22

Latest Post

  • Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg
  • Central Bank of India Launches Pioneering TReDS Insurance Policy In Strategic Partnership With TATA AIG
  • Bangur Concrete Launches First RMC Plant in Karnataka, Enters South India Market
  • Gateway Distriparks Signs Exclusive Container Train Operations Agreement for MMLP, Ankleshwar
  • RBI grants NBFC license to Equirus Group


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024